Supernus Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Supernus Pharmaceuticals, Inc.

Supernus Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of products for the treatment of central nervous system (CNS) diseases in the United States. Its commercial products are Trokendi XR, an extende…

Drug Manufacturers - Specialty & Generic
US, Rockville [HQ]

Document Reader

Click To Read:

DEF 14-A Proxies

Not a single DEF 14-A proxy doc.

10-K Filings

Not a single 10-K doc.

10-Q Filings

Not a single 10-Q doc.

LDA 1/2 Filings [Lobbying]

Not a single LDA doc.

End of SUPN's Analysis
CIK: 1356576 CUSIP: 868459108 ISIN: US8684591089 LEI: - UEI: -
Secondary Listings
SUPN has no secondary listings inside our databases.